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ABSTRACT
Objective: The objective behind our study is that a mucoadhesive rectal hydrogel chitosan sodium alginate carbamazepine (CBZ) microspheres for 
the purpose of controlled release for the treatment of epilepsy to avoid the possible side effects.
Methods: The study was conducted to formulate controlled release chitosan sodium alginate CBZ microspheres with the dispersion of CBZ into the 
natural polymers chitosan and sodium alginate forming microspheres conducting along with their evaluation studies.
Results: The formulated microspheres were subjected to various evaluation parameters, and all the physical parameters examined are within the 
acceptable limits. Further, the optimized microsphere formulation (CM5) was characterized. Hence, the developed optimized microsphere formulation 
(CM5) seems to be a viable substitute to conventional drug delivery system for the effective management of epilepsy.
Conclusion: The prepared formulation also provides a desired CBZ loaded sodium alginate microspheres with the controlled release drug delivery.
Keywords: Carbamazepine, Sodium alginate microspheres, Particle size.
INTRODUCTION
Epilepsy is a persistent long lasting medical neurological state or 
situation characterized by repeated, frequent and occasional seizures 
as a part of abnormal signal variation from neurons, affecting 1% of 
worldwide population. Excessive, subnormal or inordinate electrical 
discharges from nerve cells of brain cause these epileptic seizures. 
There are several reasons for epilepsy, leading to different types of 
epileptic seizures and syndromes, of which most common serious 
one is chronic epilepsy which may be caused due to brain tumors’ 
or stroke. These seizures can be properly diagnosed and treated 
with appropriate anticonvulsant medication, while some cases 
need surgery. The treatment of epilepsy depends on several factors 
such as health, medical history, age of individuals, and severity and 
frequency of seizures caused. Hence, epileptic seizures should be 
properly diagnosed for selecting appropriate treatment [1]. Most of 
the anticonvulsant drugs are associated with side effects and these 
side effects are proportional to the doses of the drug, i.e., Higher the 
dose, greater will be the side effects. Hence, antiepileptic drugs should 
be started at low dose to reduce side effects [1-3]. Side effects also 
depend on type of medication and length of medication. Common 
side effects include fatigue, sleeplessness, weight gain stomach upset, 
blurred vision, hair loss, liver problems, gingivitis, and tremor. This 
work focuses on the preparation and evaluation of a mucoadhesive 
rectal hydrogel microspheres using a mixture of natural polymers for 
the purpose of sustaining the drug release for the efficient treatment 




Carbamazepine (CBZ) was provided as a gift sample by Bajaj Private 
Limited, Mumbai, India. Chitosan was purchased from Central Institute 
of Fisheries and Technology, Kochi. India. All other materials used were 
of pharmaceutical grade.
Preformulation studies
For the rational development of drug dosage form, preformulation 
studies are considered as the preliminary and important step. The 
information and investigations obtained from these studies are 
designed to deliver important data’s of drug-like physicochemical, 
physicomechanical, bio-pharmaceutical properties of drug substances 
and its excipients as well as its compatibility [4].
Identification of drug
Fourier transform infrared (FTIR) spectroscopy
FTIR of standard drug spectra (from monograph, Indian 
Pharmacopoeia) was compared with the obtained spectrum of the 
pure drug of CBZ.
Solubility studies
The drug (CBZ) solubility in different solvents such as water, ethanol, 
methanol, 1-propanol, 1-butanol, acetone, and in phosphate buffer 
pH 6.8 was determined.
Melting point
Purity of the obtained drug sample (CBZ) is marked by its melting point. 
Open capillary method is used to determine melting point of the drug. 
Lowering of melting point is seen in the presences of relative small 
amount of impurities.
Partition coefficient
Partition coefficient of CBZ in n-octanol water system was determined. 
Into a separating funnel, equal volume of n-octanol and water was 
taken then added a known amount of CBZ. Then, the funnel was shaken 
continuously for 2 hrs at constant temperature, after 2 hrs the aqueous 
layer was detected by ultraviolet (UV) spectroscopy. The partition 
coefficient is the ratio of amount of drug in organic or lipid layer to 
concentration of drug in aqueous phase [5].
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λmax of the CBZ in methanol
λmax of CBZ was determined insolvent methanol. Standard stock solution 
prepared by following, for few minutes 50 mg CBZ was sonicated and 
dissolved in 30 ml methanol and volume was made up to 50 ml mark 
using methanol. From the standard stock solution (1000 µg/ml), 
different aliquots were diluted with water separately to prepare a 
series of concentration from 8 to 18 µg/ml. These were scanned from 
400 to 200 nm using UV spectrophotometer [6,7].
Analytical methods [8]
Calibration curve of CBZ in methanol and phosphate buffer pH 6.8 was 
done.
Calibration curve of CBZ
a. Preparation of standard stock solution:
 About 50 mg of CBZ was added to 30 ml methanol and sonication for 
10 minutes. The volume was made up to 50 ml mark using methanol. 
The drug was dissolved and diluted to make a concentration of 
1000 µg/ml.
b. Preparation of standard graph:
 From the above prepared stock solution (1000 µg/ml), different 
aliquots were withdrawn into 10 ml standard flask and diluted 
with methanol separately to prepare a series of concentration from 
range 8 to 18 µg/ml. The standard stock solution (1000 µg/ml) 
was scanned in the range of 400-200 nm against methanol as 
blank. Standard graph was obtained by plotting absorbance against 
concentration (µg/ml) [8,9].
Formulation of CBZ loaded chitosan sodium alginate microspheres 
(Fig. 1 and Table 1)
Characterization of CBZ chitosan sodium alginate  
microspheres [10-13]
The prepared microsphere was characterized for particle size, 
entrapment efficiency, in vitro drug release studies, scanning electron 
microscopy (SEM), etc.
Particle size by optical microscopy
Optical microscopic method (Olympus Opto System, India) is used for 
finding the size of microspheres.
Entrapment efficiency [14]
Determination of the concentration of entrapped drug is done by 
lysing the microspheres by sonication in phosphate buffer of pH 6.8. 
Drug CBZ filled or loaded microspheres was exactly weighed and was 
dissolved in 25 ml of phosphate buffer of pH 6.8, sonicated the solution 
Fig. 1: Preparation of carbamazepine chitosan sodium alginate microspheres
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for 15 minutes and then extracted for 12 hrs. 1 ml aliquot of this 
solution was then dissolved in 10 ml of phosphate buffer pH 6.8, then 
spectrometrically determined the concentration of loaded drug CBZ in 
phosphate buffer of pH 6.8 at 285.5 nm. Each sample was examined in 
triplicate.
In vitro release studies of drug [15-17]
Drug discharge from loaded microsphere in in vitro studies was done 
using USP – Type II paddle dissolution apparatus. For studying the 
percentage drug release from prepared microspheres, CBZ loaded 
microsphere was accurately weighed from each batch and was 
taken in 900 ml of dissolution medium (phosphate buffer pH 6.8). 
The solution as stirred at 100 rpm by maintaining 37±0.5°C as 
temperature. Aliquots of 5 ml solution were periodically withdrawn 
at regular intervals, for determining the concentration of the drug, at 
the same time 5 ml was replaced with blank which was also analyzed 
spectrophotometrically at 285.5 nm release studies were carried out 
in triplicate.
SEM [18,19]
With an adhesive carbon tape, the optimized or the perfect microsphere 
formulation was mounted on an aluminum stub after diluting it with 
distilled water, it was sputter-coated with gold using a vacuum 
evaporator and examined in SEM for 5-10 minutes at 40 mA and then 




FTIR of obtained pure drug CBZ in Fig. 2 was found to be in conformity 
with the monograph (IP) (Fig. 3).
Solubility studies
The pure drug is partially soluble in water and ethanol and completely 
soluble in methanol, phosphate buffer pH 6.8 as mentioned in Table 2.
Melting point of the drug
The drug was found to melt at a temperature of 188-193°C and it was in 
accordance with that of the reference.
Partition coefficient
The drug was found to be insoluble in water proving that it is highly 
lipophilic, by showing a partition coefficient value of 1.59.
λmax CBZ in methanol
The absorption maxima of CBZ in methanol was found to be 285 nm 
as shown in Fig. 4 which was in accordance with the official standard.
λmax of CBZ in phosphate buffer pH 6.8
The absorption maxima of CBZ in pH 6.8 phosphate buffer was found to 
be 285.5 nm (Fig. 5).
Analytical method by UV spectrophotometer
Preparation of calibration curve for CBZ in methanol
The standard graph gave a straight line which indicates calibration 
curve is linear in the concentration range of 8-18 µg/mL. The calibration 
curves were shown in Table 3 and Fig. 6.
Preparation of calibration curve for CBZ in phosphate buffer 
pH 6.8
The calibration curve was linear in the concentration range of 
3-18 µg/ml. The calibration curves were shown in Table 4 and Fig. 7.
Formulation of CBZ chitosan sodium alginate microspheres
The chitosan sodium alginate microspheres were prepared by injecting 
drug and sodium alginate mixture into already prepared chitosan 
Fig. 2: Fourier transform infrared spectrum of carbamazepine 
according to monograph (IP)
Table 1: Formulation composition of CBZ chitosan Na alginate 
microspheres
S.No. Ingredients CM1 CM2 CM3 CM4 CM5 CM6
1 Chitosan (g) 1 1.5 2 2.5 3 3.5
2 CBZ (mg) 60 60 60 60 60 60
3 Sodium alginate (g) 3.2 3.2 3.2 3.2 3.2 3.2
4 Heavy liquid paraffin (ml) 100 100 100 100 100 100
5 Light liquid paraffin (ml) 50 50 50 50 50 50
6 Acetic acid 3% (ml) 15 151 15 15 15 15
7 Tween 80 (ml) 1.5 1.5 1.5 1.5 1.5 1.5
CBZ: Carbamazepine










Table 3: Absorbance value of CBZ in methanol







Values are expressed as mean±standard deviation, n=3. CBZ: Carbamazepine
Table 4: Absorbance value of CBZ in phosphate buffer pH 6.8







Values are expressed as mean±standard deviation, n=3. CBZ: Carbamazepine
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Fig. 3: Fourier transform infrared spectrum of sample carbamazepine active pharmaceutical ingredient
Fig. 4: Absorption maxima of carbamazepine in methanol
Fig. 5: Absorption maxima of carbamazepine in phosphate buffer 
pH 6.8
Fig. 7: Calibration curve for carbamazepine in phosphate buffer 
pH 6.8
Fig. 6: Calibration curve for carbamazepine in methanol
solution which contains light liquid paraffin, heavy liquid paraffin 
and SPAN 80. The prepared microspheres were filtered finally dried 
to obtain chitosan sodium alginate microspheres. The microspheres 
obtained were smooth and spherical in shape.
Characterization of CBZ chitosan Na alginate microspheres
Particle size by optical microscopy
The particle size of the microspheres was in the range between 70 and 
100 µm.
Entrapment efficiency
Entrapment efficiency is the measure of solute retention. The 
entrapment efficiency of all microsphere formulations ranged between 
62.67±0.29% and 92.56±0.72% as shown in Table 5 and Fig. 8. The 
maximum entrapment efficiency was found to be 92.56±0.72% for 
microsphere formulation CM5. Entrapment efficiency of the drug in 
microsphere increases as polymer concentration is proportional to 
viscosity; higher polymer concentration means higher will be the 
viscosity. This lead to larger polymers/solvent droplets to be formed, 
and more will be the time for hardening of larger particles allowing 
time for drug diffusion out of the particles which tend to decrease drug 
release.
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apparatus using Phosphate buffer pH 6.8 dissolution medium. The 
drug concentrations were determined spectrophotometric method at 
285.5 nm.21-23 CM5 formulation showed maximum controlled release 
shown in Fig. 9.
SEM
SEM was executed to examine the surface morphology of the 
microspheres. SEM images for CM5 formulation shown in Fig. 10 
confirm spherical nature of microspheres with smooth surface. The 
average particle size of microspheres was around 2-5 µm.
CONCLUSION
For fighting against epilepsy, a novel drug delivery system to combat 
this incurable firing disorder is yet to be developed. Antiepileptic 
medications are used as the first line treatment option, but 
conventional therapy is accompanied by a handful of side effects. 
This study aimed to develop CBZ sodium chitosan microspheres 
which could minimize the side effects by dose reduction and 
bypasses first pass metabolism. CBZ Na alginate microspheres have 
been prepared and evaluated. The CBZ Na alginate microspheres 
(CM5) shows adequate rheological, mucoadhesive and permeability 
properties. The suggested formula allows the drug CBZ to the rectal 
mucosa for subsequent sustained release behavior with no burst 
effect, which is a major disadvantage of CBZ immediate release 
systems. In vitro release kinetics of formulation clearly indicated 
that the CBZ microsphere exhibited zero order release. The study 
emerged as a successful attempt to reduce dosing frequency and 
drug-related adverse drug reaction by producing sustained releasing 
microspheres.
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Values are expressed as mean±standard deviation, n=3
Fig. 8: Entrapment efficiency of microsphere formulations. Values 
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Fig. 9: In vitro drug release studies
Fig. 10: Carbamazepine loaded rice bran wax microsphere (CM5)
In vitro drug release studies
The percentage of drug release from the prepared microspheres 
was studied by USP Type II paddle apparatus dissolution rate 
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